To determine the real‐world frequency of EGFR ex20ins, we analysed data from three NGS genomic datasets that included patients with NSCLC: GENIE (N = 12 497), FoundationInsights (N = 56 382), and GuardantINFORM (N = 71 191). Here, EGFR is linked to non-small cell lung carcinoma.